Automated Galectin-3 Blood Test Launch - Report on BG Medicine PR Newswire NEW YORK, July 21, 2015 NEW YORK, July 21, 2015 /PRNewswire/ -- ACI Association has initiated research coverage on BG...
Net Loss Reduced by 38% and Operating Cash Burn Cut by 42% from First Quarter 2014 Outlook Improved for 2015 WALTHAM, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc...
WALTHAM, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, May 14, 2015 at 8:30 a.m...
WALTHAM, Mass., March 31, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, today reported that it has filed a 510(k) Premarket...
Net Loss Reduced by 49% and Operating Cash Burn Cut by 47% From 2013 First Automated Galectin-3 Testing Expected to Launch in U.S. in Mid-2015 WALTHAM, Mass., March 31, 2015 (GLOBE...
WALTHAM, Mass., March 26, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today the publication of a landmark study, in the Journal of the American College of Cardiology...
WALTHAM, Mass., March 24, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Tuesday, March 31, 2015 at 8:30 am...
WALTHAM, Mass., March 13, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) (the "Company"), the developer of the BGM Galectin-3® Test, today announced its receipt of a notice of...
WALTHAM, Mass., Feb. 2, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, announced today its receipt of a favorable decision from the...
Net Loss Reduced by 60% and Operating Cash Burn Cut by 44% From First Quarter 2013 Continued Progress Made Toward Delivering on Critical Catalysts for Growth WALTHAM, Mass., May 14, 2014...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 45457 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 33374 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 21940 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 0.00013 | 1.0E-6 | 16180 | 1.07E-6 | CS |
156 | 0 | 0 | 1.0E-6 | 0.02 | 1.0E-6 | 11392 | 0.0001444 | CS |
260 | -0.029999 | -99.9966666667 | 0.03 | 0.257 | 1.0E-6 | 16598 | 0.04835122 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales